Harvard Bioscience (HBIO) Other Non Operating Income (2010 - 2026)
Harvard Bioscience (HBIO) reported Other Non Operating Income of -$405000.0 for Q1 2026, down 109.84% year-over-year from $4.1 million in Q1 2025, and up 69.39% quarter-over-quarter from -$1.3 million in Q4 2025.
Harvard Bioscience (HBIO) Other Non Operating Income (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Other Non Operating Income data on file, last reported at -$405000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$405000.0, down 109.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.7 million (down 627.93% YoY), and the FY2025 annual result was -$2.7 million, down 717.23% from the prior year.
- Other Non Operating Income improved to -$405000.0 in Q1 2026 per HBIO's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $516000.0 in Q4 2024 and troughed at -$1.3 million in Q4 2025.
- A 5-year average of -$187058.8 and a median of -$181000.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Other Non Operating Income surged 453.85% in 2023, then plunged 1251.11% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at $465000.0 in 2022, then plunged by 171.4% to -$332000.0 in 2023, then jumped by 255.42% to $516000.0 in 2024, then tumbled by 356.4% to -$1.3 million in 2025, then jumped by 69.39% to -$405000.0 in 2026.
- Business Quant data shows HBIO's Other Non Operating Income at -$405000.0 in Q1 2026, -$1.3 million in Q4 2025, and -$365000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -405,000.00 |
| Dec 31, 2025 | -1.32 Mn |
| Sep 30, 2025 | -365,000.00 |
| Jun 30, 2025 | -644,000.00 |
| Mar 31, 2025 | -193,000.00 |
| Dec 31, 2024 | 516,000.00 |
| Sep 30, 2024 | -518,000.00 |
| Jun 30, 2024 | -181,000.00 |
| Mar 31, 2024 | -142,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | -372,000.00 |
| Mar 31, 2023 | 432,000.00 |
| Dec 31, 2022 | 465,000.00 |
| Sep 30, 2022 | -179,000.00 |
| Jun 30, 2022 | -62,000.00 |
| Mar 31, 2022 | 78,000.00 |
| Dec 31, 2021 | -189,000.00 |
| Sep 30, 2021 | -130,000.00 |
| Jun 30, 2021 | -313,000.00 |